Hemostatic Agent Development

Award Information

Agency: Department of Defense	Branch: Navy	Award ID: 98527	Program Year/Program: 2010 / SBIR
Agency Tracking Number: N101-085-1139	Solicitation Year: N/A	Solicitation Topic Code: NAVY 10-085	Solicitation Number: N/A

Small Business Information: HYBRID PLASTICS
55 WL Runnels Industrial Drive Hattiesburg, MS -
View profile »

Woman-Owned: No

Minority-Owned: No

HUBZone-Owned: No

Phase 1: Fiscal Year: 2010

Title: Hemostatic Agent Development

Agency / Branch: DOD / NAVY

Contract: N00014-10-M-0481

Award Amount: $70,000.00

Abstract:
The proposed effort comprises a treatment combination using the platelet binding hemostatic capability of Nanoscopic Chemicals known as POSS trisilanols in combination with hyaluronic acid media, and antibiotic drugs in liquid and foam form. Mechanistically, liquid POSS trisilanols are injectable and serve to bind platelets to immediately stop bleeding. Subsequently the bound plateles release a multitude of natural growth factors while in the presence of a supplement of Hyaluronic acid (HA). Growth factors in combination with high amounts of HA are known to aid tissue repair and preservation.

Principal Investigator:
Joseph Lichtenhan
President
6015443466
Lichtenhan@hybridplastics.com

Business Contact:
Carl Hagstrom
Chief Operating Officer
6015443466
Chagstrom@hybridplastics.com

Small Business Information at Submission:

Hybrid Plastics
55 W. L. Runnels Industrial Dr. Hattiesburg, MS 39401

EIN/Tax ID: 900146195

DUNS: N/A

Number of Employees:

Woman-Owned: No

Minority-Owned: No

HUBZone-Owned: No